Protein inhibitor drugs

Classification of the Main Protein Tyrosine Kinase Families and Their Inhibitor Drugs. Tofacitinib, a Janus kinase inhibitor, is the drug that has

Immunotherapy drugs called immune checkpoint inhibitors work by blocking checkpoint proteins from binding with their partner proteins.

Immunotherapy drugs called immune checkpoint inhibitors work by blocking checkpoint proteins from binding with their partner proteins.

PP2A inhibitor. Potent protein phosphatase 2A (PP2A) inhibitor. At higher concentrations, also inhibits protein phosphatase 1 (PP1).

Immunotherapy drugs called immune checkpoint inhibitors work by blocking checkpoint proteins from binding with their partner proteins.

Protein kinase inhibitors are drugs that can inhibit the action of protein kinases. Protein kinases add a phosphate group to a protein to switch it on or off.

Attachment inhibitors are a newer class of HIV drug. They work by attaching to a viral protein, which prevents the viral protein from attaching to and entering

Dabrafenib acts as an inhibitor of the BRAF protein and slows down or stops the growth of cancer cells while trametinib acts against the MEK protein. The drugs

The different classes of drugs used with protease inhibitors each inhibit certain proteins to target different parts of the virus. These can include: NS5A protein inhibitors